Publications
Search our database of publications on vaccines for COVID-19. These include published scientific papers, preprints and policy reports, and all are from teams based in the UK.
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) are frequently treated with immunosuppressive treatments that can affect serological responses to SARS-CoV-2 vaccination. On Sept 1, 2021, the Joint Committee on Vaccination and Immunisation recommended a third dose for immunosuppressed patients, with patients with IBD eligible after Nov 26, 2021.
